Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹165 Cr.
Stock P/E
282.9
P/B
5
Current Price
₹64
Book Value
₹ 12.9
Face Value
10
52W High
₹72
52W Low
₹ 32.5
Dividend Yield
0%

Vaxfab Enterprise Overview

Business

Vaxfab Enterprises Ltd. operates in the trading sector in India. Its core business involves buying and selling various goods or commodities with the aim of generating profit from the margin between purchase and sale prices. The company's business model likely focuses on sourcing products from manufacturers or suppliers, managing logistics, and distributing them to customers, which could include other businesses (B2B) or directly to consumers (B2C), depending on its specific focus areas.

Revenue Mix

Based on the information provided, Vaxfab Enterprises Ltd. operates predominantly within a single "Trading" segment. Specific breakdown of revenue by product category, geographic region, or customer type is not disclosed. Revenue is primarily derived from sales of traded goods.

Industry

The Indian trading industry is generally highly fragmented and competitive, characterized by low barriers to entry for many types of goods. Companies in this sector often compete on price, efficiency of supply chain, quality of relationships with suppliers and customers, and working capital management. Without specific details on Vaxfab's niche, scale, or product portfolio, its precise positioning relative to peers is difficult to ascertain, but it operates within a dynamic and price-sensitive market environment.

MOAT

In the general trading sector, durable competitive advantages (moats) are often challenging to establish due to the commoditized nature of many goods and low switching costs. Potential sources of competitive advantage for Vaxfab could include strong, long-standing supplier relationships, efficient logistics and supply chain management, deep understanding of specific product markets, effective working capital management, or a robust distribution network. However, based solely on the "Trading" description, significant sustainable moats are not evident.

Growth Drivers

Key factors that could drive growth for Vaxfab Enterprises Ltd. over the next 3-5 years include:

Overall economic growth in India, leading to increased demand for various goods and commodities.

Expansion into new product categories or niches with higher margins or growing demand.

Geographical expansion within India or into international markets (if applicable).

Improved supply chain efficiencies and cost management, enhancing profitability.

Development of stronger relationships with both suppliers and customers, securing better terms or exclusive distribution rights.

Risks

Commodity Price Volatility: Fluctuations in the prices of goods traded can significantly impact margins and inventory valuation.

Intense Competition: The fragmented nature of the trading industry can lead to price wars and reduced profitability.

Inventory Risk: Holding inventory carries risks of obsolescence, damage, and price depreciation, requiring effective inventory management.

Supply Chain Disruptions: Dependence on various suppliers and logistics partners makes the company vulnerable to disruptions (e.g., natural disasters, geopolitical events, transport issues).

Credit Risk: Risk of non-payment or delayed payment from customers, impacting cash flow.

Working Capital Management: Effective management of receivables, payables, and inventory is crucial for profitability in trading businesses.

Management & Ownership

Information regarding the promoters, specific management quality, and detailed ownership structure of Vaxfab Enterprises Ltd. is not provided. In India, promoter groups typically hold significant stakes in publicly listed companies and often play a direct role in management.

Outlook

Vaxfab Enterprises Ltd. operates in the fundamental trading sector, which is integral to economic activity. The outlook for the company is tied to its ability to navigate the inherent challenges of this sector. A positive scenario could see the company leveraging economic growth in India, identifying lucrative trading niches, and optimizing its supply chain and working capital management to sustain healthy margins. Conversely, intense competition, significant volatility in commodity prices, or inadequate inventory and credit management could put pressure on profitability and growth. Its long-term success will likely hinge on its agility, efficiency, and ability to forge strong, lasting relationships within its supply and distribution networks.

Vaxfab Enterprise Share Price

Live · BSE · Inception: 1983
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Vaxfab Enterprise Quarterly Results

#(Fig in Cr.) Mar 2022 Jun 2022 Mar 2023 Jun 2023 Dec 2024 Mar 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 0 0 14 4 46 24 16 46 0
Other Income 0 0 0 0 0 1 -3 14 3
Total Income 0 0 14 4 46 25 12 60 4
Total Expenditure 0 0 14 4 39 31 15 57 6
Operating Profit 0 0 0 0 6 -6 -3 4 -2
Interest 0 0 0 0 0 0 0 -0 0
Depreciation 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 6 -6 -3 4 -2
Provision for Tax 0 0 0 0 0 -7 0 2 1
Profit After Tax 0 0 0 0 6 1 -3 2 -3
Adjustments 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 6 1 -3 2 -3
Adjusted Earnings Per Share 0.4 0 0.3 0.3 7.6 0.9 -3.9 2.6 -1.2

Vaxfab Enterprise Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 TTM
Net Sales 0 17 86
Other Income 0 0 15
Total Income 0 17 101
Total Expenditure 0 16 109
Operating Profit 0 0 -7
Interest 0 0 0
Depreciation 0 0 0
Exceptional Income / Expenses 0 0 0
Profit Before Tax 0 1 -7
Provision for Tax 0 0 -4
Profit After Tax 0 0 -3
Adjustments 0 0 0
Profit After Adjustments 0 0 -3
Adjusted Earnings Per Share 0 0.5 -1.6

Vaxfab Enterprise Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023
Shareholder's Funds 3 16
Minority's Interest 0 0
Borrowings 0 0
Other Non-Current Liabilities 0 0
Total Current Liabilities 0 10
Total Liabilities 3 27
Fixed Assets 0 0
Other Non-Current Assets 1 12
Total Current Assets 2 14
Total Assets 3 27

Vaxfab Enterprise Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0
Cash Flow from Operating Activities -0 2
Cash Flow from Investing Activities 0 -12
Cash Flow from Financing Activities 0 14
Net Cash Inflow / Outflow 0 4
Closing Cash & Cash Equivalent 0 4

Vaxfab Enterprise Ratios

# Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.01 0.46
CEPS(Rs) 0.05 0.47
DPS(Rs) 0 0
Book NAV/Share(Rs) 11.88 19.3
Core EBITDA Margin(%) -32.32 2.76
EBIT Margin(%) 1.32 3.04
Pre Tax Margin(%) 1.21 3.02
PAT Margin (%) 0.92 2.33
Cash Profit Margin (%) 4.18 2.38
ROA(%) 0.08 2.62
ROE(%) 0.09 4.08
ROCE(%) 0.11 5.1
Receivable days 1078.4 52.5
Inventory Days 207.54 52.75
Payable days 0 111.02
PER(x) 1029.41 34.71
Price/Book(x) 0.9 0.83
Dividend Yield(%) 0 0
EV/Net Sales(x) 10.42 0.59
EV/Core EBITDA(x) 227.3 21.44
Net Sales Growth(%) 0 6045.63
EBIT Growth(%) 0 0
PAT Growth(%) 0 0
EPS Growth(%) 0 4359.62
Debt/Equity(x) 0.01 0.02
Current Ratio(x) 63.32 1.42
Quick Ratio(x) 58.08 0.96
Interest Cover(x) 12 124.27
Total Debt/Mcap(x) 0.01 0.03

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR — — — —
Operating Profit CAGR — — — —
PAT CAGR — — — —
Share Price CAGR +92% +55% +50% —
ROE Average +4% +2% +2% +2%
ROCE Average +5% +3% +3% +3%

Vaxfab Enterprise Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 0 %
FII 0.04 %
DII (MF + Insurance) 0 %
Public (retail) 99.96 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 0000000000
FII 0000000.60.60.130.04
DII 0000000000
Public 10010010010010010099.499.499.8799.96
Others 0000000000
Total 100100100100100100100100100100

Vaxfab Enterprise Peer Comparison

Vaxfab Enterprise Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Vaxfab Enterprise Pros & Cons

Pros

Cons

  • Promoter holding is low: 0%.
  • Company has a low return on equity of 2% over the last 3 years.
  • Debtor days have increased from 0 to 111.02days.
  • Stock is trading at 5 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp